Starpharma Holdings LimitedASX: SPL

AstraZeneca presents 1st DEP candidate as Bcl2/xL inhibitor

Sep 28, 2017 at 6:10 AM UTC · Issued by Starpharma Holdings Limited

Starpharma Holdings Ltd has released a press release.

View Attachment